Aflac Incorporated, known for its supplemental health and life insurance products, operates successfully across two major regions: the U.S and Japan. This diversified geographical presence provides a competitive edge. The company's strong fundamentals, balanced with moderate debt, indicate a promising position in the market.
Aflac shows a solid overall performance with strengths in equity returns and asset management, though some challenges may exist in the debt-equity sphere.
Category | Score | Visualization |
---|---|---|
Overall | 4 | |
Discounted Cash Flow | 4 | |
Return on Equity | 5 | |
Return on Assets | 5 | |
Debt to Equity | 2 | |
Price to Earnings | 3 | |
Price to Book | 1 |
The historical data reflects consistent scores, with recent improvements in key areas suggesting positive future prospects.
Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-04-24 | 4 | 4 | 5 | 5 | 2 | 3 | 1 |
Historical | 0 | 4 | 5 | 5 | 2 | 3 | 1 |
Analyst price targets point towards a consistent consensus, indicating stability and limited volatility in expected stock performance.
High | Low | Median | Consensus |
---|---|---|---|
102 | 102 | 102 | 102 |
The sentiment among analysts is predominantly neutral, with a majority holding a steady position on the stock.
Recommendation | Count | Visualization |
---|---|---|
Strong Buy | 0 | |
Buy | 9 | |
Hold | 14 | |
Sell | 2 | |
Strong Sell | 0 |
Aflac Incorporated presents a robust investment opportunity with stable returns on equity and assets, while moderate risks arise from its debt levels. The company's forward momentum appears healthy, reinforced by a consistent analyst price consensus. However, potential investors should remain cautious of any market changes that could impact the insurance industry. Overall, Aflac's diversified portfolio and geographical spread provide a solid foundation for future growth.